Moderna Inc (MRNA)

148.07 +1.15 (+0.78%)
Real-time Cboe USD Disclaimer

MRNA Financial Summary

Moderna, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 19,263 million compared to USD 18,471 million a year ago. Net income was USD 8,362 million compared to USD 12,202 million a year ago. Basic earnings per share from continuing operations was USD 21.26 compared to USD 30.31 a year ago. Diluted earnings per share from continuing operations was USD 20.12 compared to USD 28.29 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
MRNA
Gross margin TTM 54.78%
Operating margin TTM 48.9%
Net Profit margin TTM 43.41%
Return on Investment TTM 45.79%
Total Revenue
Net Income
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Revenue 5,084 3,364 4,749 6,066
Gross Profit 1,955 1,444 2,658 4,495
Operating Income 1,580 1,166 2,447 4,227
Net Income 1,465 1,043 2,197 3,657
Clear All
0Selected
Please try another search
MRNA
Quick Ratio MRQ 2.29
Current Ratio MRQ 2.73
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 6.28%
Total Assets
Total Liabilities
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Assets 25,858 26,056 26,043 27,609
Total Liabilities 6,735 8,064 8,058 10,534
Total Equity 19,123 17,992 17,985 17,075
Clear All
0Selected
Please try another search
MRNA
Cash Flow/Share TTM 12.97
Revenue/Share TTM 50.14
Operating Cash Flow 33.76%
Cash
Net Change in Cash
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Cash From Operating Activities 1,662 252 304 2,763
Cash From Investing Activities -1,048 945 -1,152 -3,921
Cash From Financing Activities -438 -1,041 -1,327 -642
Net Change in Cash 176 156 -2,175 -1,800
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.